Zobrazeno 1 - 10 of 824 pro vyhledávání: '"Gf, Koob"'
2
Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system
Autor: Marianne Amalric, Gf, Koob
Publikováno v: Europe PubMed Central
In summary, evidence is presented that the mesocorticolimbic and nigrostriatal dopamine systems form functionally selective afferents to different parts of the basal ganglia and these inputs are paralleled by functionally selective outputs. The ventr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bf69fc7dfcd0274f190807e1345ec5cc
https://pubmed.ncbi.nlm.nih.gov/8108549
Zobrazit plný text záznamu
5
Neurochemical substrates for opiate reinforcement
Autor: Gf, Koob, Fj, Vaccarino, Marianne Amalric, Fe, Bloom
Publikováno v: Europe PubMed Central
The studies reported herein summarize our work to date aimed at determining the neurochemical substrates for the reinforcing properties of opiates. Rats were trained to self-administer heroin intravenously in daily 3-hour sessions, and pharmacologica
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f479aabc73b5d28cae5307994b49c700
https://pubmed.ncbi.nlm.nih.gov/3025733
Zobrazit plný text záznamu
6
Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens
Autor: Trevor Robbins, Dc, Roberts, Gf, Koob
Publikováno v: Europe PubMed Central
After training under a fixed-interval 60 sec schedule of food presentation in the presence of a water tube (to permit schedule-induced licking), groups of rats received either 6-hydroxy-dopamine (6-OHDA)(8 micrograms base/2 microliters) or 0.2% ascor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::37ed13f8e1f89c9f9a6bf38c3ba4d63d
http://europepmc.org/abstract/med/6402587
Zobrazit plný text záznamu
7
Akademický článek
PET imaging in rat brain shows opposite effects of acute and chronic alcohol exposure on phosphodiesterase-4B, an indirect biomarker of cAMP activity.
Autor: Tang S; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Kim SW; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA., Olsen-Dufour A; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Pearson T; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA., Freaney M; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA., Singley E; Clinical Core Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA., Jenkins M; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Burkard NJ; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA., Wozniak A; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA., Parcon P; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Wu S; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Morse CL; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Jana S; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Liow JS; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Zoghbi SS; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Vendruscolo JCM; Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Baltimore, MD, USA., Vendruscolo LF; Stress and Addiction Neuroscience Unit, Integrative Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, Baltimore, MD, USA., Pike VW; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA., Koob GF; Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Baltimore, MD, USA., Volkow ND; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA. nvolkow@nida.nih.gov., Innis RB; Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA. robert.innis@nih.gov.
Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 Dec; Vol. 50 (2), pp. 444-451. Date of Electronic Publication: 2024 Sep 16.
Zobrazit plný text záznamu
8
Akademický článek
The mGlu5 receptor negative allosteric modulator mavoglurant reduces escalated cocaine self-administration in male and female rats.
Autor: Vendruscolo LF; Stress and Addiction Neuroscience Unit, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, National Institutes of Health, BRC Room 08A727, 251 Bayview Blvd, Baltimore, MD, 21224, USA. leandro.vendruscolo@nih.gov., Vendruscolo JCM; Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, 21224, USA., Whiting KE; Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, 21224, USA., Acri JB; Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, 20892, USA., Volkow ND; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA., Koob GF; Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, 21224, USA.
Publikováno v: Psychopharmacology [Psychopharmacology (Berl)] 2024 Nov; Vol. 241 (11), pp. 2303-2313. Date of Electronic Publication: 2024 Jun 13.
Zobrazit plný text záznamu
9
Akademický článek
The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain development.
Autor: Volkow ND; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Gordon JA; National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA., Bianchi DW; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA., Chiang MF; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Clayton JA; Office of Research on Women's Health, National Institutes of Health, Bethesda, MD, USA., Klein WM; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Koob GF; National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Koroshetz WJ; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Pérez-Stable EJ; National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA., Simoni JM; Office of Behavioral and Social Sciences Research, National Institutes of Health, Bethesda, MD, USA., Tromberg BJ; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, USA., Woychik RP; National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA., Hommer R; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Spotts EL; Office of Behavioral and Social Sciences Research, National Institutes of Health, Bethesda, MD, USA., Xu B; National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA., Zehr JL; National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA., Cole KM; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA. Electronic address: katherine.cole@nih.gov., Dowling GJ; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Freund MP; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Howlett KD; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Jordan CJ; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Murray TM; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Pariyadath V; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Prabhakar J; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Rankin ML; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Sarampote CS; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Weiss SRB; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Publikováno v: Developmental cognitive neuroscience [Dev Cogn Neurosci] 2024 Oct; Vol. 69, pp. 101423. Date of Electronic Publication: 2024 Jul 27.
Zobrazit plný text záznamu
10
Akademický článek
GHSR blockade, but not reduction of peripherally circulating ghrelin via β 1 -adrenergic receptor antagonism, decreases binge-like alcohol drinking in mice.
Autor: Richardson RS; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore and Bethesda, MD, USA.; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; University of North Carolina School of Medicine MD/PhD Program, University of North Carolina, Chapel Hill, NC, USA.; Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA.; Stress and Addiction Neuroscience Unit, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, MD, USA., Kryszak LA; National Institute on Drug Abuse Intramural Research Program Translational Analytical Core, National Institutes of Health, Baltimore, MD, USA., Vendruscolo JCM; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; Stress and Addiction Neuroscience Unit, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, MD, USA., Koob GF; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Vendruscolo LF; Stress and Addiction Neuroscience Unit, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, MD, USA. leandro.vendruscolo@nih.gov., Leggio L; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore and Bethesda, MD, USA. lorenzo.leggio@nih.gov.; National Institute on Drug Abuse Intramural Research Program Translational Analytical Core, National Institutes of Health, Baltimore, MD, USA. lorenzo.leggio@nih.gov.; Department of Behavioral and Social Sciences, Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA. lorenzo.leggio@nih.gov.; Medication Development Program, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA. lorenzo.leggio@nih.gov.; Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. lorenzo.leggio@nih.gov.; Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA. lorenzo.leggio@nih.gov.
Publikováno v: Molecular psychiatry [Mol Psychiatry] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje